首页> 美国卫生研究院文献>OncoTargets and therapy >Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma

【2h】

Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma

机译：HMGB1的抑制作用克服了鼻咽癌对放射线和化学疗法的耐药性。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

This study aimed to investigate the effect of high mobility group protein B1 (HMGB1) on chemoresistance and radioresistance in nasopharyngeal carcinoma (NPC).

机译：本研究旨在研究高迁移率族蛋白B1（HMGB1）对鼻咽癌（NPC）化学耐药性和放射抵抗性的影响。

著录项

期刊名称 OncoTargets and therapy
作者
Xuewei Zhu; Jianan Cong; Zhang Lin; Jing Sun; Ben Yang; Aipeng Li;
展开▼
作者单位

展开▼
年(卷),期 2020(13),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
NPC; HMGB1; NHEJ; resistance; Ku70; glycyrrhizin;

机译：NPC;HMGB1;NHEJ;电阻;Ku70;甘草甜素;

相似文献

外文文献
中文文献
专利

1. Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma [J] . Xuewei Zhu, Jianan Cong, Zhang Lin, OncoTargets and therapy . 2020,第2期

机译：抑制HMGB1克服了鼻咽癌的辐射和化疗的耐药性
2. Impact of Intensity Modulated Radiation Therapy (IMRT) on the Benefit of Concurrent Chemotherapy With or Without Adjuvant Chemotherapy in Localized Nasopharyngeal Carcinoma Versus Radiation Therapy Alone: Meta-analysis of Results from Non-IMRT and IMRT St [J] . Tan T. H., Soon Y. Y., Cheo T., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：强度调节放射治疗（IMRT）对局部鼻咽癌的同时化疗的影响（IMRT）对局部鼻咽癌与放射治疗的影响：NOR-IMRT和IMRT ST的结果
3. A Randomized Phase 2 Trial of Induction Chemotherapy and Concurrent Chrono-chemotherapy With Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma [J] . Zhang P., Jin F., Li Z., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：局部晚期鼻咽癌辐射治疗诱导化疗的随机阶段2试验及同时计时化疗
4. Analysis of the Curative Effect of the Treatment of the Three-dimensional Conformal Radiotherapy Combination with the Induction Chemotherapy in the Middle-late Nasopharyngeal Carcinoma [C] . Min Ma, Hongying Lin, Shengcun Zhang International Forum on Bioinformatics and Medical Engineering . 2015

机译：三维保形放疗与中期鼻咽癌诱导化疗治疗疗效分析
5. Acquired rituximab resistance is associated with cross -resistance to chemotherapy that is overcome by treatment with bortezomib. [D] . Olejniczak, Scott Henry. 2007

机译：获得性利妥昔单抗耐药性与对化疗的交叉耐药性相关，而硼替佐米治疗可以克服这种交叉耐药性。
6. Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225 [O] . Nancy Lee, Jonathan Harris, Adam S. Garden, -1

机译：鼻咽癌有无化疗的调强放射疗法：放射疗法肿瘤学小组II期试验0225
7. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level. : Chemotherapy overcomes TRAIL-R4 inhibition [O] . Morizot, Alexandre, Mérino, Delphine, Lalaoui, Najoua, 2011

机译：化学疗法在DISC水平上克服了TRAIL-R4介导的TRAIL耐药性。：化学疗法克服了TRAIL-R4的抑制作用

Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅